Latest / GSD Venture Studios Podcasts by Gary Fowler
Scaling Human Bioequivalence: The New Frontier of Organoids and AI with Daniel Delubac
Join Daniel Delubac, CEO of IORGANBIO, for a deep dive into the breakthrough technologies reshaping modern medicine. From non-invasive prenatal testing to the first AI-agentic platforms for synthetic chemistry, Daniel has been at the center of the world's most significant biotech innovations. In this episode, we explore how IORGANBIO is merging first-principles engineering with AI to manufacture human bioequivalent cells and organoids at scale—replacing outdated animal models and paving the way for accessible, $n$-of-one regenerative medicine.🎯 Insights You’ll Learn:✓ The Power of NAMs: Why…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.